Search
Search Results
##search.searchResults.foundPlural##
-
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1200PDF: 452HTML: 18542Figure 1: 154Figure 2: 138Figure 3: 154Figure 4: 187Figure 5: 157 -
Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature
1815PDF: 873HTML: 1742Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated AML- IMAGES: 143 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1691PDF: 655HTML: 314 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3209PDF: 1309HTML: 2608 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
3748PDF: 3077HTML: 182 -
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1348PDF: 901HTML: 289 -
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
1984PDF: 1600HTML: 345 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3426PDF: 2333HTML: 1411 -
ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE
0PDF: 0Suppl. Files: 0HTML: 0 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1329PDF: 656HTML: 1067Untitled: 165Untitled: 130Untitled: 114Untitled: 137Untitled: 143 -
-
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2162PDF: 927HTML: 1869 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1182PDF: 699HTML: 291 -
-
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
1973PDF: 1460HTML: 259 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1215PDF: 514HTML: 22992 -
VASCULAR ENDOTHELIAL GROWTH FACTOR IN CHILDREN WITH THALASSEMIA MAJOR PDF
1239PDF: 831HTML: 1023Figure 1 the correlation between frequency of blood transfusion and serum vascular endothelial growth factor (VEGF).: 155 -
-
Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report Liver involvement in familial Mediterranean fever
1213PDF: 873HTML: 279 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2077PDF: 1929HTML: 143 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1648PDF: 793HTML: 137 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2620PDF: 978HTML: 2154 -
Pidotimod in paucisymptomatic SARS-CoV2 infected patients Pidotimod in COVID-19
2956PDF: 1841HTML: 957 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3429PDF: 1579HTML: 2662 -







